Chronobiology, sleep-related risk factors and light therapy in perinatal depression: the "Life-ON" project

Simone Baiardi, Fabio Cirignotta, Alessandro Cicolin, Corrado Garbazza, Armando D'Agostino, Orsola Gambini, Alessandra Giordano, Mariapaola Canevini, Elena Zambrelli, Anna Maria Marconi, Susanna Mondini, Stefan Borgwardt, Christian Cajochen, Nicola Rizzo, Mauro Manconi, Simone Baiardi, Fabio Cirignotta, Alessandro Cicolin, Corrado Garbazza, Armando D'Agostino, Orsola Gambini, Alessandra Giordano, Mariapaola Canevini, Elena Zambrelli, Anna Maria Marconi, Susanna Mondini, Stefan Borgwardt, Christian Cajochen, Nicola Rizzo, Mauro Manconi

Abstract

Background: Perinatal depression (PND) has an overall estimated prevalence of roughly 12 %. Untreated PND has significant negative consequences not only on the health of the mothers, but also on the physical, emotional and cognitive development of their children. No certain risk factors are known to predict PND and no completely safe drug treatments are available during pregnancy and breastfeeding. Sleep and depression are strongly related to each other because of a solid reciprocal causal relationship. Bright light therapy (BLT) is a well-tested and safe treatment, effective in both depression and circadian/sleep disorders.

Methods: In a 3-year longitudinal, observational, multicentre study, about 500 women will be recruited and followed-up from early pregnancy (10-15 gestational week) until 12 months after delivery. The primary aim of the present study is to systematically explore and characterize risk factors for PND by prospective sleep assessment (using wrist actigraphy, polysomnography and various sleep questionnaires) and bloodbased analysis of potential markers during the perinatal period (Life-ON study). Secondary aims are to explore the relationship between specific genetic polymorphisms and PND (substudy Life-ON1), to investigate the effectiveness of BLT in treating PND (substudy Life-ON2) and to test whether a short term trial of BLT during pregnancy can prevent PND (substudy Life-ON3).

Discussion: The characterization of specific predictive and risk factors for PND may substantially contribute to improve preventive medical and social strategies for the affected women. The study results are expected to promote a better understanding of the relationship between sleep disorders and the development of PND and to confirm, in a large sample of women, the safety and efficacy of BLT both in prevention and treatment of PND.

Trial registration: ClinicalTrials.gov NCT02664467 . Registered 13 January 2016.

Keywords: Actigraphy; Chronobiology; Circadian rhythms; Light therapy; Perinatal depression; Polysomnography; Pregnancy; Sleep; Sleep disorders.

Figures

Fig. 1
Fig. 1
Flowchart of the study design. Legend: D: depression; M: month; ND: no depression; PND: perinatal depression; PPD: postpartum depression

References

    1. O’Hara MW, Gorman LL, Wright EJ. Description and evaluation of the Iowa depression awareness, recognition, and treatment program. Am J Psychiatry. 1996;153:645–9. doi: 10.1176/ajp.153.5.645.
    1. Cox JL, Murray D, Chapman G. A controlled study of the onset, duration and prevalence of postnatal depression. Br J Psychiatry. 1993;163:27–31. doi: 10.1192/bjp.163.1.27.
    1. Steiner M. Perinatal mood disorders: position paper. Psychopharmacol Bull. 1998;34:301–6.
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed., text rev. Washington, DC: American Psychiatric Association; 2000.
    1. Gjerdingen DK, Yawn BP. Postpartum depression screening: importance, methods, barriers, and recommendations for practice. J Am Board Fam Med. 2007;20:280–8. doi: 10.3122/jabfm.2007.03.060171.
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5. Arlington: American Psychiatric Publishing; 2013.
    1. Accortt EE, Schetter CD. Pregnant women screening positive for depressive symptoms at 24–28 weeks may have increased risk of preterm birth but more precise research is needed. Evid Based Nurs. 2014;17:11–2. doi: 10.1136/eb-2012-101164.
    1. Hamdan A, Tamim H. The relationship between postpartum depression and breastfeeding. Int J Psychiatry Med. 2012;43:243–59. doi: 10.2190/PM.43.3.d.
    1. Oates M. Suicide: the leading cause of maternal death. Br J Psychiatry. 2003;183:279–81. doi: 10.1192/bjp.183.4.279.
    1. Goodman SH, Gotlib IH. Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev. 1999;106:458–90. doi: 10.1037/0033-295X.106.3.458.
    1. Petrou S, Cooper P, Murray L, Davidson LL. Economic costs of post-natal depression in a high-risk British cohort. Br J Psychiatry. 2002;181:505–12. doi: 10.1192/bjp.181.6.505.
    1. Räisänen S, Lehto SM, Nielsen HS, Gissler M, Kramer MR, Heinonen S. Risk factors for and perinatal outcomes of major depression during pregnancy: a population-based analysis during 2002–2010 in Finland. BMJ Open. 2014;4:e004883. doi: 10.1136/bmjopen-2014-004883.
    1. Epstein RA, Moore KM, Bobo WV. Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges. Drug Healthc Patient Saf. 2014;6:109–29. doi: 10.2147/DHPS.S43308.
    1. McDonagh MS, Matthews A, Phillipi C, Romm J, Peterson K, Thakurta S, Guise JM. Depression drug treatment outcomes in pregnancy and the postpartum period: a systematic review and meta-analysis. Obstet Gynecol. 2014;124:526–34. doi: 10.1097/AOG.0000000000000410.
    1. Wolfson AR, Crowley SJ, Anwer U, Bassett JL. Changes in sleep patterns and depressive symptoms in first-time mothers: last trimester to 1-year postpartum. Behav Sleep Med. 2003;1:54–67. doi: 10.1207/S15402010BSM0101_6.
    1. Chang JJ, Pien GW, Duntley SP, Macones GA. Sleep deprivation during pregnancy and maternal and fetal outcomes: is there a relationship? Sleep Med Rev. 2010;14:107–14. doi: 10.1016/j.smrv.2009.05.001.
    1. Pail G, Huf W, Pjrek E, Winkler D, Willeit M, Praschak-Rieder N, et al. Bright-light therapy in the treatment of mood disorders. Neuropsychobiology. 2011;64:152–62. doi: 10.1159/000328950.
    1. Oldham MA, Ciraulo DA. Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system. Chronobiol Int. 2014;31:305–19. doi: 10.3109/07420528.2013.833935.
    1. Zisapel N. Circadian rhythm sleep disorders: pathophysiology and potential approaches to management. CNS Drugs. 2001;15:311–28. doi: 10.2165/00023210-200115040-00005.
    1. Terman M, Terman JS. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectr. 2005;10:647–63. doi: 10.1017/S1092852900019611.
    1. Corral M, Kuan A, Kostaras D. Bright light therapy’s effect on postpartum depression. Am J Psychiatry. 2000;157:303–4. doi: 10.1176/appi.ajp.157.2.303-a.
    1. Epperson CN, Terman M, Terman JS, Hanusa BH, Oren DA, Peindl KS, et al. Randomized clinical trial of bright light therapy for antepartum depression: preliminary findings. J Clin Psychiatry. 2004;65:421–5. doi: 10.4088/JCP.v65n0319.
    1. Oren DA, Wisner KL, Spinelli M, Epperson CN, Peindl KS, Terman JS, et al. An open trial of morning light therapy for treatment of antepartum depression. Am J Psychiatry. 2002;159:666–9. doi: 10.1176/appi.ajp.159.4.666.
    1. Corral M, Wardrop AA, Zhang H, Grewal AK, Patton S. Morning light therapy for postpartum depression. Arch Womens Ment Health. 2007;10:221–4. doi: 10.1007/s00737-007-0200-1.
    1. Wirz-Justice A, Bader A, Frisch U, Stieglitz RD, Alder J, Bitzer J, et al. A randomized, double-blind, placebo-controlled study of light therapy for antepartum depression. J Clin Psychiatry. 2011;72:986–93. doi: 10.4088/JCP.10m06188blu.
    1. Crowley SK, Youngstedt SD. Efficacy of light therapy for perinatal depression: a review. J Physiol Anthropol. 2012;31:15. doi: 10.1186/1880-6805-31-15.
    1. McClung CA. Circadian rhythms and mood regulation: insights from pre-clinical models. Eur Neuropsychopharmacol. 2011;21(Suppl 4):S683–93. doi: 10.1016/j.euroneuro.2011.07.008.
    1. Dallaspezia S, Benedetti F. Chronobiological therapy for mood disorders. Expert Rev Neurother. 2011;11:961–70. doi: 10.1586/ern.11.61.
    1. Dallaspezia S, Benedetti F. Sleep deprivation therapy for depression. Curr Top Behav Neurosci. 2015;25:483–502. doi: 10.1007/7854_2014_363.
    1. Steiger A, Pawlowski M, Kimura M. Sleep electroencephalography as a biomarker in depression. ChronoPhysiol Ther. 2015;5:15–25. doi: 10.2147/CPT.S41760.
    1. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W. Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep. 2008;31:473–80.
    1. Gupta MA, Simpson FC. Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med. 2015;11:165–75.
    1. Hornyak M. Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management. CNS Drugs. 2010;24:89–98. doi: 10.2165/11317500-000000000-00000.
    1. Mindell JA, Cook RA, Nikolovski J. Sleep patterns and sleep disturbances across pregnancy. Sleep Med. 2015;16:483–8. doi: 10.1016/j.sleep.2014.12.006.
    1. Bourjeily G, Raker CA, Chalhoub M, Miller MA. Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing. Eur Respir J. 2010;36:849–55. doi: 10.1183/09031936.00021810.
    1. O’Brien LM, Bullough AS, Owusu JT, Tremblay KA, Brincat CA, Chames MC, et al. Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol. 2012;207: 487.e1-9. doi: 10.1016/j.ajog.2012.08.034.
    1. Manconi M, Govoni V, De Vito A, Economou NT, Cesnik E, Casetta I, et al. Restless legs syndrome and pregnancy. Neurology. 2004;63:1065–9. doi: 10.1212/01.WNL.0000138427.83574.A6.
    1. Lawson A, Murphy KE, Sloan E, Uleryk E, Dalfen A. The relationship between sleep and postpartum mental disorders: a systematic review. J Affect Disord. 2015;176:65–77. doi: 10.1016/j.jad.2015.01.017.
    1. Wesström J, Skalkidou A, Manconi M, Fulda S, Sundström-Poromaa I. Pre-pregnancy restless legs syndrome (Willis-Ekbom Disease) is associated with perinatal depression. J Clin Sleep Med. 2014;10:527–33.
    1. Rosenthal NE, Sack DA, Gillin JC, Lewy AJ, Goodwin FK, Davenport Y, et al. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry. 1984;41:72–80. doi: 10.1001/archpsyc.1984.01790120076010.
    1. Lieverse R, Van Someren EJ, Nielen MM, Uitdehaag BM, Smit JH, Hoogendijk WJ. Bright light treatment in elderly patients with nonseasonal major depressive disorder: a randomized placebo-controlled trial. Arch Gen Psychiatry. 2011;68:61–70. doi: 10.1001/archgenpsychiatry.2010.183.
    1. Terman M, Terman JS. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry. 1999;60:799–808. doi: 10.4088/JCP.v60n1113.
    1. Gallin PF, Terman M, Remé CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995;119:202–10. doi: 10.1016/S0002-9394(14)73874-7.
    1. Walsh MJ, Atkinson LA, Corlett SA, Lall GS. An insight into light as a chronobiological therapy in affective disorders. ChronoPhysiol Ther. 2014;4:79–85.
    1. Lucas RJ, Lall GS, Allen AE, Brown TM. How rod, cone, and melanopsin photoreceptors come together to enlighten the mammalian circadian clock. Prog Brain Res. 2012;199:1–18. doi: 10.1016/B978-0-444-59427-3.00001-0.
    1. Lam RW, Zis AP, Grewal A, Delgado PL, Charney DS, Krystal JH. Effects of rapid tryptophan depletion in patients with seasonal affective disorder in remission after light therapy. Arch Gen Psychiatry. 1996;53:41–4. doi: 10.1001/archpsyc.1996.01830010043007.
    1. Neumeister A, Praschak-Rieder N, Besselmann B, Rao ML, Glück J, Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psychiatry. 1997;54:133–8. doi: 10.1001/archpsyc.1997.01830140043008.
    1. aan het Rot M, Benkelfat C, Boivin DB, Young SN. Bright light exposure during acute tryptophan depletion prevents a lowering of mood in mildly seasonal women. Eur Neuropsychopharmacol. 2008;18:14–23. doi: 10.1016/j.euroneuro.2007.05.003.
    1. Baïlara KM, Henry C, Lestage J, Launay JM, Parrot F, Swendsen J, et al. Decreased brain tryptophan availability as a partial determinant of post-partum blues. Psychoneuroendocrinology. 2006;31:407–13. doi: 10.1016/j.psyneuen.2005.10.001.
    1. Kammerer M, Taylor A, Glover V. The HPA axis and perinatal depression: a hypothesis. Arch Womens Ment Health. 2006;9:187–96. doi: 10.1007/s00737-006-0131-2.
    1. O’Keane V, Lightman S, Patrick K, Marsh M, Papadopoulos AS, Pawlby S, et al. Changes in the maternal hypothalamic-pituitary-adrenal axis during the early puerperium may be related to the postpartum “blues”. J Neuroendocrinol. 2011;23:1149–55. doi: 10.1111/j.1365-2826.2011.02139.x.
    1. Berry RB, Brooks R, Gamaldo CE, et al. Darien, IL: American Academy of Sleep Medicine; 2014. for the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications, Version 2.0.3. .
    1. Lecrubier Y, Sheehan D, Weiller E, Amorim P, Bonora I, Sheehan K, et al. The Mini International Neuropsychiatric Interview (MINI). a short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12:224–31. doi: 10.1016/S0924-9338(97)83296-8.
    1. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh postnatal depression scale. Br J Psychiatry. 1987;150:782–6. doi: 10.1192/bjp.150.6.782.
    1. Ahearn EP. The use of visual analog scales in mood disorders: a critical review. J Psychiatr Res. 1997;5:569–79. doi: 10.1016/S0022-3956(97)00029-0.
    1. Hamilton M. Development of a rating scale; for primary depressive illness. Br J Soc Clin Psychol. 1967;6:278–96. doi: 10.1111/j.2044-8260.1967.tb00530.x.
    1. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9. doi: 10.1192/bjp.134.4.382.
    1. Cloninger R, Przybeck TR, Svrakic DM, Wetzel RD. The temperament and character inventory (TCI): a guide to its development and use. St. Louis: Center for Psychobiology of Personality, Washington University; 1994.
    1. Paykel ES. The interview for recent life events. Psychol Med. 1997;27:301–10. doi: 10.1017/S0033291796004424.
    1. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Morin CM, Belleville G, Belanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601–8.
    1. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:50–5.
    1. Allen RP, Picchietti DL, Garcia-Borreguero D, Ondo WG, Walters AS, Winkelman JW, et al. International Restless Legs Syndrome Study Group. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance. Sleep Med. 2014;15:860–73. doi: 10.1016/j.sleep.2014.03.025.
    1. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C. International Restless Legs Syndrome Study Group. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med. 2003;4:121–32. doi: 10.1016/S1389-9457(02)00258-7.
    1. Fulda S, Hornyak M, Müller K, Cerny L, Beitinger PA, Wetter TC. Entwicklung und Validierung des Münchner Parasomnie-Screening (MUPS): Ein Fragebogen zur Erfassung von Parasomnien und nächtlichen Verhaltensweisen. Somnologie. 2008;12:56–65. doi: 10.1007/s11818-008-0336-x.
    1. Horne JA, Östberg O. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol. 1976;4:97–110.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다